The role of growth factors in wound healing

Journal of Trauma - Injury, Infection and Critical Care

Volumn 41, Issue 1, 1996, Pages 159-167

  Greenhalgh, David G ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Clinical trials; Cytokines; Epidermal growth factor; Fibroblast growth factor; Growth factors; Insulin like growth factors; Platelet derived growth factor; Transforming growth factor ; Transforming growth factor ; Wound healing

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; CELL CONTACT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; WOUND HEALING;

EID: 0030054791     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199607000-00029     Document Type: Review

References (133)

1. Sporn MB, Roberts AB: Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 78:329, 1986
2. Druker BJ, Mamon HJ, Roberts TM: Oncogenes, growth factors, and signal transduction. N Engl J Med 321:1383, 1989
3. Gilman AG: G proteins and regulation of adenylyl cyclase. JAMA 262:1819, 1989
4. Nishizuka Y: The family of protein kinase C for signal transduction. JAMA 262:1826, 1989
5. Berridge MJ: Inositol triphosphate, calcium, lithium, and cell signaling. JAMA 262:1834, 1989
6. Quinn MT: Low-molecular-weight GTP-binding proteins and leukocyte signal transduction. J Leukoc Biol 58:263, 1995
7. Levitzki A, Gazit A: Tyrosine kinase inhibition: An approach to drug development. Science 267:1782, 1995
8. Ghosh A, Greenberg ME: Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science 268:239, 1995
9. Mochly-Rosen D: Localization of protein kinases by anchoring proteins: A theme in signal transduction. Science 268:247, 1995
10. Heldin C-H, Ostman A, Westermark B: Structure of platelet-derived growth factor: Implications for functional properties. Growth Factors 8:245, 1993
11. Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 46:155, 1986
12. Hart CE, Bailey M, Curtis DA, et al: Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all PDGF dimers in human platelets. Biochemistry 29:166, 1990
13. Hart CE, Forstrom JW, Kelly JD, et al: Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240:1529, 1988
14. Leung DW, Cachianes G, Kuang W-J, et al: Vascular endothelial growth factor is secreted angiogenic mitogen. Science 246:1306, 1989
15. Mason IJ: The ins and outs of fibroblast growth factors. Cell 78:547, 1994
16. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor family. Adv Cancer Res 60:1, 1993
17. Rubin JS, Osada H, Finch PW, et al: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86:802, 1989
18. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1, 1993
19. Miyazono K, Ichijo H, Heldin C-H: Transforming growth factor-β: Latent forms, binding proteins and receptors. Growth Factors 8:11, 1993
20. Shah M, Foreman DM, Ferguson MWJ: Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 339:213, 1992
21. Ferguson MWJ: Control of scarring. Proceedings of the Joint Meeting of the Wound Healing Society and the European Tissue Repair Society. 1:46, 1993
22. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693, 1992
23. Cohen S: The epidermal growth factor (EGF). Cancer 51:1789, 1983
24. Olsen PS, Poulsen SS, Therkelson K, et al: Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology 90:911, 1986
25. Derynck R: Transforming growth factor-α: Structure and biologic activities. J Cell Biochem 32:293-304, 1986
26. Downward J, Yarden Y, Mayes E, et al: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521, 1984
27. Merimee TJ, Zapf J, Hewlett B, et al: Insulin-like growth factors in pygmies: The role of puberty in determining final stature. N Engl J Med 316:906, 1987
28. Stiles CD, Capone GT, Scher CD, et al: Dual role of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279, 1979
29. Rotwein P: Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5:3, 1991
30. Nissley P, Lopaczynski W: Insulin-like growth factor receptors. Growth Factors 5:29, 1991
31. Dennis PA, Rifkin DB: Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580, 1991
32. Roman JR, McDonald JA: Cellular processes in lung repair. Chest 100:245, 1991
33. Friedman SL: The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 328: 1828, 1993
34. Ross R: The pathogenesis of atherosclerosis. N Engl J Med 314:488, 1986
35. Cromack DT, Sporn MB, Roberts AB, et al: Transforming growth factor β levels in rat wound chambers. J Surg Res 42:622, 1987
36. Matsuoka J, Grotendorst GR: Two peptides related to platelet-derived growth factor are present in human wound fluid. Proc Natl Acad Sci USA 86:4416, 1989
37. Dvonch VM, Murphey RJ, Matsuoka J, et al: Changes in growth factor levels in human wound fluid. Surgery 112:18, 1992
38. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, et al: Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 19:401, 1993
39. Ono I, Gunji H, Suda K, et al: Evaluation of cytokines in donor site wound fluids. Scand J Plast Reconstr Hand Surg 28:269, 1994
40. Bennett NT, Schultz GS: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 166:74, 1993
41. Alaish SM, Bettinger DA, Olutoye OO, et al: Comparison of the polyvinyl sponge and expanded polytetrafluoroethylene subcutaneous implants as models to evaluate wound healing potential in human beings. Wound Repair and Regeneration 3:292, 1995
42. Agren MS, Taplin CJ, Woessner JF, JR, et al: Collagenase in wound healing: Effect of wound age and type. J Invest Dermatol 99:709, 1992
43. Stricklin GP, Nanney LB: Immunolocalization of collagenase and TIMP in healing burn wounds. J Invest Dermatol 103:488, 1994
44. Prager MD, Baxter CR, Hartline B: Proteolytic activity in burn wound exudates and comparison of fibrin degradation products and protease inhibitors in exudates and sera. J Burn Care Rehabil 15:130, 1994
45. Brown RL, Greenhalgh DG, Neely A: Determination of matrix metalloproteinase activity and mRNA expression in burn wounds. Proceedings of the American Burn Association 27:56, 1995
46. Steenfos H, Lossing C, Hansson HA: Immunohistochemical demonstration of endogenous growth factors in wound healing. Wounds 2:218, 1990
47. Gibran NS, Isik FF, Gordon D, et al: Basic fibroblast growth factor in the early human burn wound. Proceedings of the American Burn Association 24:30, 1992
48. Gartner MH, Benson JD, Caldwell MD: Time course of epidermal growth factor mRNA expression in healing wounds using polymerase chain reaction. Surg Forum 42:643, 1991
49. Gartner MH, Benson JD, Caldwell MD: Time course of TGF-beta 1 and 2 expression in the healing wound. Proceedings of the Wound Healing Society 2:3, 1992
50. Gartner MH, Richards JR, Caldwell MD: Interrelationships between growth factor messenger RNA and protein product in the healing wound. Surg Forum 43:683, 1992
51. Whitby DJ, Ferguson MWJ: Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 147:207, 1991
52. Wong DTW, Donoff RB, Yang J, et al: Sequential expression of transforming growth factors α and β1 by eosinophils during cutaneous wound healing in the hamster. Am J Pathol 143:130, 1993
53. Appleton I, Tomlinson A, Colville-Nash PR, et al: Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue: Implications for their role in tissue development and repair processes. Lab Invest 69:405, 1993
54. Antoniades HN, Galanopoulos T, Neville-Golden J, et al: Injury induces in vivo expression of Platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci USA 88:565, 1991
55. Brasken P, Renvall S, Sandberg M: Expression of epidermal growth factor and epidermal growth factor receptor genes in healing colonie anastomoses in rats. Eur J Surg 157:607, 1991
56. Peus D, Jungtaubl H, Knaub S, et al: Localization of platelet-derived growth factor receptor subunit expression in chronic venous leg ulcers. Wound Repair and Regeneration 3:265, 1995
57. Wenczak B, Nanney L, Lynch JB: Evidence for a functional epidermal growth factor receptor in burn wounds. Proceedings of the American Burn Association 24:27, 1992
58. Werner S, Breeden M, Greenhalgh DG, et al: Induction of keratinocyte growth factor is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol 103:469, 1994
59. Goretsky MJ, Greenhalgh DG: Delayed expression of IGF-II but not TGF-β1 in wounds of diabetic mice. Proceedings of the Association of Academic Surgery 29:123, 1995
60. Frank S, Hubner G, Breier G, et al: Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 270:12607, 1955
61. Salomon GD, Kasid A, Bernstein E, et al: Gene expression in normal and doxorubicin-impaired wounds: Importance of transforming growth factor-beta. Surgery 108:318, 1990
62. Brown RL, Ormsby I, Doetschman TC, et al: Wound healing in the transgenic TGF-β1 deficient mouse. Wound Rep Reg 3:25, 1995
63. Brown GL, Curtsinger L, Brightwell JR, et al: Enhancement of epidermal regeneration by synthetic epidermal growth factor. J Exp Med 163:1319, 1986
64. Schultz GS, White M, Mitchell R, et al: Epithelial wound healing enhanced by transforming growth factor-α and vaccinia growth factor. Science 235:350, 1987
65. Jones SC, Curtsinger LJ, Whalen JD, et al: Effect of topical recombinant TGF-β on healing of partial thickness injuries. J Surg Res 51:344, 1991
66. Sprugel KH, McPherson JM, Clowes AW, et al: Effects of growth factors in vivo: I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 129:601, 1987
67. Pierce GF, Mustoe TA, Senior RM, et al: In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 167:974, 1988
68. Mustoe TA, Pierce GF, Thomason A, et al: Accelerated healing of incisional in rats induced by transforming growth factor-β. Science 237:1333, 1987
69. McGee GS, Davidson JM, Buckley A, et al: Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 45:145, 1988
70. Leitzel K, Cano C, Marks Jr JG, et al: Growth factors and wound healing in the hamster. J Dermatol Surg Oncol 11:617, 1985
71. Pierce GF, Mustoe TA, Lingelbach J, et al: Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol 109:429, 1989
72. Beck LS, Chen TL, Mikalauski P, et al: Recombinant human transforming growth factor-beta 1 (rhTGF-β1) enhances healing and strength of granulation skin wounds. Growth Factors 3:267, 1990
73. Ksander GA, Ogawa Y, Chu GH, et al: Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann Surg 211:288, 1990
74. Hebda PA, Klingbeil CK, Abraham JA, et al: Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 95:626, 1990
75. Staiano-Coico L, Krueger JG, Rubin JS, et al: Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 178:865, 1993
76. Grotendorst GR, Martin GR, Pencev D, et al: Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 76:2323, 1985
77. Greenhalgh DG, Sprugel KH, Murray MJ, et al: PDGF and FGF stimulate healing in the genetically diabetic mouse. Am J Pathol 136:1235, 1990
78. Klingbeil CK, Cesar LB, Fiddes JC: Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res 365:443, 1991
79. Tsuboi R, Rifkin DB: Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 172:245, 1990
80. Broadley KN, Aquino AM, Hicks B, et al: The diabetic rat as an impaired wound healing model: Stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol Ther 1:55, 1989
81. Albertson S. Hummel RP III, Breeden M, et al: PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery 114:368, 1993
82. Hayward P, Hokanson J, Heggars J, et al: Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg 163:288, 1992
83. Zhao LL, Davidson JD, Wee SC, et al: Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 129:1043, 1994
84. Mustoe TA, Ahn ST, Tarpley JE, et al: Role of hypoxia in growth factor responses: Differential effects of basic fibroblast growth factor and platelet-derived growth factor in an ischemic wound model. Wound Repair and Regeneration 2:277, 1994
85. Wu L, Mustoe TA: Effect of ischemia on growth factor enhancement of incisional wound healing. Surgery 117:570, 1995
86. Lawrence WT, Sporn MB, Gorschboth C, et al: The reversal of an Adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg 203:142, 1986
87. Laato M, Heino J, Kahari VM, et al: Epidermal growth factor (EGF) prevents methylprednisolone-induced inhibition of wound healing. J Surg Res 47:354, 1989
88. Pierce GF, Mustoe TA, Lingelbach J, et al: Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA 86:2229, 1989
89. Beck LS, DeGuzman L, Lee WP, et al: TGF-β1 accelerates wound healing: Reversal of steroid-impaired healing in rats and rabbits. Growth Factors 5:295, 1991
90. Mustoe TA, Purdy J, Gramates P, et al: Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Am J Surg 158:345, 1989
91. Greenhalgh DG, Hummel RP III, Albertson S, et al: Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo: Enhancement of tissue repair in genetically diabetic mice. Wound Repair and Regeneration 1:69, 1993
92. Lynch SE, Nixon JC, Colvin RB, et al: Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci USA 84:7696, 1987
93. Lynch SE, Colvin RB, Antoniades HN: Growth factors in wound healing: Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 84:640, 1989
94. Lynch SE, Buser D, Hernandez TA, et al: Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 62:710, 1991
95. Lynch SE, Ruiz de Castilla G, Williams RC, et al: The effects of short term application of a combination of platelet-derived and insulin-like growth factors on peridontal wound healing. J Periodontol 62:458, 1991
96. Hennessey PJ, Black CT, Andrassy RJ: Epidermal growth factor and insulin act synergistically during diabetic healing. Arch Surg 125:926, 1990
97. Brown RL, Breeden MP, Greenhalgh DG: PDGF and TGF-α act synergistically to improve healing in the genetically diabetic mouse. J Surg Res 56:562, 1994
98. Jyung RW, Mustoe TA, Busby WH, et al: Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery 115:233, 1994
99. Tsuboi R, Shi C-M, Sato C, et al: Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Dermatol 104:199, 1995
100. Knighton DT, Fiegel VE, Austin LL, et al: Classification and treatment of chronic nonhealing wounds: Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204:322, 1986
101. Knighton DR, Ciresi K, Fiegel VD, et al: Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170:56, 1990
102. Atri SC, Misra J, Bisht D, et al: Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 108:508, 1990
103. Steed D, Goslen B, Abell E, et al: Clinical trials with purified platelet releasate. Prog Clin Biol Res 365:103, 1991
104. Steed DL, Goslen JB, Holloway GA, et al: Randomized prospective double-blind trial in healing chronic diabetic foot ulcers: CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15:1598, 1992
105. Krupski WC, Reilly LM, Perez S, et al: A prospective randomized trial of autologous platelet-derived healing factors for treatment of chronic nonhealing wounds: A preliminary report. J Vasc Surg 14:526, 1991
106. Phillips TJ, Gilchrest BA: Cultured epidermal allografts as biological wound dressings. Prog Clin Biol Res 365:77, 1991
107. DeLuca M, Albanese E, Bondanza S, et al: Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 15:303, 1989
108. Blight A, Fatah MF, Datubo-Brown DD, et al: The treatment of donor sites with cultured epithelial grafts. Br J Plast Surg 44:12, 1991
109. Goretsky MJ, Harriger MD, Supp AP, et al: Expression of IL-1α, IL-6 and bFGF by cultured skin substitutes before and after to full-thickness wounds in athymic mice. J Trauma 40:in press, 1996
110. Robson MC, Phillips LG, Thomason A, et al: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339:23, 1992
111. Robson MC, Phillips LG, Lawrence WT, et al: The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216:401, 1992
112. Robson MC, Phillips LG, Thomason A, et al: Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg 29:193, 1992
113. Mustoe TA, Cutler NR, Allman RM, et al: A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 129:213, 1994
114. Robson MC, Phillip LG, Cooper DM, et al: Safety and effect of transforming growth factor-beta, for treatment of venous stasis ulcers. Wound Repair and Regeneration 3:157, 1995
115. Steed DL, the Diabetic Ulcer Study Group: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 21:71, 1995
116. Falanga V, Eaglstein WH, Bucalo B, et al: Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 18:604, 1992
117. Robson MC, Abdullah A, Burns BF, et al: Safety and effect of topical recombinant human interleukin-1β in the management of pressure sores. Wound Repair and Regeneration 2:177, 1994
118. Mazue G, Bertolero F, Jacob C, et al: Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci 638:329, 1991
119. Brown GL, Nanney LB, Griffin J, et al: Enhancement of wound healing by tropical treatment with epidermal growth factor. N Engl J Med 321:76, 1989
120. Cohen IK, Crossland MC, Garrett A, et al: Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization. Plast Reconstr Surg 96:251, 1995
121. Greenhalgh DG, Rieman M: Effects of basic fibroblast growth factor on the healing of partial-thickness donor sites: A prospective, randomized, double-blinded trial. Wound Repair and Regeneration 2:113, 1994
122. Barbul A. The effects of interleukin-1 on the healing of split thickness donor sites. Reported at the 47th Annual Sessions of the Forum on Fundamental Surgical Problems at the Clinical Congress of the American College of Surgeons, Chicago, October 20-25, 1991
123. Herndon DN, Barrow RE, Kunkel KR, et al: Effects of human growth hormone on donor-site healing in severely burned children. Ann Surg 212:424, 1990
124. Gilpin DA, Barrow RE, Rutan RL, et al: Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 220:19, 1994
125. Deitch EA, Wheelahan TM, Rose MP, et al: Hypertrophic burn scars: Analysis of variables. J Trauma 23:895, 1983
126. Eisinger M, Sadan S, Silver IA, et al: Growth regulation of skin cells by epidermal cell derived factors: Implications for wound healing. Proc Natl Acad Sci USA 85:1937, 1988
127. Ghahary A, Shen YJ, Scott PG, et al: Enhanced expression of mRNA for transformed growth factor-β, type I and type III procollagen in human post-burn hypertrophic scar tissue. J Lab Clin Med 122:465, 1993
128. Zhang K, Garner W, Cohen L, et al: Increased types I and III collagen and transforming growth factor-β1 mRNA and protein in hypertrophie burn scar. J Invest Dermatol 104:750, 1995
129. Rosenbloom J, Feldman G, Freundlich B, et al: Transcriptional control of human diploid fibroblast collagen synthesis by gamma interferon. Biochem Biophys Res Commun 123:365, 1984
130. Granstein RD, Murphy GF, Margolis RJ, et al: Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 79:1254, 1987
131. Berman B, Duncan MR: Short-term treatment in vivo with human interferon alpha-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol 21:694, 1989
132. Granstein RD, Rook A, Flotte TJ, et al: A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Arch Dermatol 126:1295, 1990
133. Tredgett EE, Shen YJ, Liu G, et al: Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophie scar fibroblasts in vitro by interferon alfa-2a. Wound Repair and Regeneration 1:156, 1993